Articles, interviews & expert comment
Next week on the stock market
Aarin Chiekrie | 13 October 2023
What to expect from a selection of FTSE 100, FTSE 250 and selected other companies reporting next week.
-
The UK’s biggest car insurers – 3 share ideas with potential
Matt Britzman | 12 October 2023
It’s been a tricky time for the UK motor insurance sector since people returned to the roads. Here are 3 share ideas that might present an opportunity.
-
3 share ideas for investing in big pharma
Derren Nathan | 12 October 2023
Big pharma could be poised for growth. Here are 3 share ideas that might be worth a look.
-
What we want to see in the 2023 autumn statement
Sarah Coles and Helen Morrissey | 11 October 2023
With Jeremy Hunt’s 2023 autumn statement around the corner, we share five things we’d like to see the chancellor of the exchequer prioritise.
-
Birkenstock IPO price range announced – what investors need to know
Charlie Hutchence | 11 October 2023
Birkenstock, the global shoemaker, has announced its IPO price range. Here’s what potential investors need to know and how to buy Birkenstock shares.
-
How the Israeli-Hamas conflict could impact your investments
Kathleen Brooks | 10 October 2023
From an oil price spike to ‘safe-haven’ assets, here’s a look at how the Israeli-Hamas conflict is impacting the global economy and stock markets, and what it means for investors.
-
Behind on your retirement plans? – 3 ways to make up for lost time
Devleena Roy | 9 October 2023
With over a fifth of retirees wishing they got to grips with retirement sooner, here are three ways to make up for lost time.
-
Next week on the stock market
Sophie Lund-Yates | 6 October 2023
What to expect from a selection of FTSE 100, FTSE 250 and selected other companies reporting next week.
-
The most popular Stocks and Shares ISA funds so far this tax year
Jason Roberts | 6 October 2023
Find out which funds are most popular with our Stocks and Shares ISA clients so far in this 2023/24 tax year.
-
Investing in big pharma – where are the opportunities?
Derren Nathan | 6 October 2023
Sales sparked by the pandemic have started falling away, but is there more opportunity in pharmaceuticals for the clued-in investor?
-
Five shares to watch 2023 – third quarter update
Aarin Chiekrie | 5 October 2023
As we near the end of the year, we check in on how our five shares to watch have performed in the third quarter.
-
Counting the cost of corporate scandals – what are they and how to avoid them
Dominic Rowles | 5 October 2023
Fraud, corruption and deceit can cost investors billions. Here’s what you should look out for and two funds that could help you avoid a corporate scandal.
-
Unlocking retirement – 4 of the most asked retirement questions and expert answers
Isabel McDougall | 3 October 2023
We take a look at some of the most commonly asked retirement questions online and share expert answers that you can trust, including ‘how much do I need to retire?’.
-
3 funds for future proofing your portfolio
Tara Clee & Joseph Hill | 3 October 2023
There are opportunities being created by the change in social and environmental trends. Here are 3 funds that could stand to benefit.
-
Fixed-rate savings maturing soon? – what you need to know
Duncan Jeffery | 2 October 2023
A wave of cash is heading for the savings market as many fixed-rate terms come to an end. If we don’t make the most of it, we could lose over a billion pounds in interest.
Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Next